landiolol has been researched along with Coronary Artery Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, K; Hirano, M; Iino, M; Ikari, Y; Jinzaki, M; Kuribayashi, S; Tanimoto, M; Yamaguchi, T; Yamashina, A | 1 |
| Ishii, H; Isobe, S; Kato, M; Kobayashi, M; Meno, C; Mimura, T; Murohara, T; Sato, K; Sugiura, K | 1 |
2 trial(s) available for landiolol and Coronary Artery Stenosis
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Blood Pressure; Coronary Angiography; Coronary Stenosis; Double-Blind Method; Female; Heart Rate; Humans; Image Enhancement; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2014 |
Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience.
Topics: Aged; Anti-Arrhythmia Agents; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2008 |